spacer
home > pmps > autumn 2018 > clean room clean-up
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Clean Room Clean-Up

Microbial management lies at the heart of Good Manufacturing Practice, and hygienic best practice dictates that up to a third of a scientistís day can typically be spent cleaning and swab testing. Clearly, this is not the most cost-effective use of time, but managing risk will always be the key priority. While any microbial contamination is unlikely to spike within a closely controlled environment, any upwards trend, regardless of how far below alert levels it is, will require additional monitoring and investigation, translating into lost time and resources. Keeping clean rooms consistently below alert level is viable though. While hard work will not be eliminated, the combination of a scrupulous hygienic standard operating procedure (SOP) with well-considered procurement choices can at least reduce the risk.

Amending the SOP can offer some scope for authorising a reduction in clean down time if it demonstrates ongoing conformance with stable results. Minimising the need to rework or expend time undergoing further investigations will free up the team to focus on the task at hand, or, as necessary, turn their attention to other areas of risk management.

While no one-size-fits-all clean room exists, given that each factors a host of variables, certain hygiene and cleaning considerations that translate to any scenario must be made.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Springett is Commercial Manager at Teknomek, which produces hygienic furniture and equipment. Having previously held similar positions in manufacturing and service industries, Sue has helped Teknomek introduce a series of new products specifically for clean room users.
spacer
Sue Springett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific
More info >>

White Papers

Igb Tamper Evident Folding Box

IGB

The easiest, safest and less expensive solution in compliance with what requires Dir. 62/2011/EU, FDA and TGA.
More info >>

 
Industry Events

Highly Potent Active Pharmaceutical Ingredients (HPAPI)

13-14 May 2019, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019. The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement